Results 311 to 320 of about 113,823 (359)
Some of the next articles are maybe not open access.
American Journal of Clinical Pathology, 1982
An acquired circulating inhibitor to Factor VIII:C was found in a 27-year-old postpartum woman who presented with ecchymoses and hematomas. Postpartum Factor VIII:C inhibitors can clinically manifest with signs and symptoms not unlike those in a classic hemophiliac.
B S, Shitamoto +2 more
openaire +2 more sources
An acquired circulating inhibitor to Factor VIII:C was found in a 27-year-old postpartum woman who presented with ecchymoses and hematomas. Postpartum Factor VIII:C inhibitors can clinically manifest with signs and symptoms not unlike those in a classic hemophiliac.
B S, Shitamoto +2 more
openaire +2 more sources
The World Federation of Hemophilia Annual Global Survey 1999‐2018
Haemophilia, 2020The World Federation of Hemophilia (WFH) strives to achieve care for all patients with inherited bleeding disorders through research, advocacy, capacity building and education.
Jeffrey S. Stonebraker +10 more
semanticscholar +1 more source
Hematology/Oncology Clinics of North America, 1992
Over the past few years considerable progress has been made in elucidating the molecular genetics of hemophilia A, in carrier detection and prenatal diagnosis, and in the production of safer clotting factor concentrates. Recombinant FVIII, shown to be safe and effective in ongoing prelicensure clinical trials that began in the spring of 1987, should ...
J M, Lusher, I, Warrier
openaire +2 more sources
Over the past few years considerable progress has been made in elucidating the molecular genetics of hemophilia A, in carrier detection and prenatal diagnosis, and in the production of safer clotting factor concentrates. Recombinant FVIII, shown to be safe and effective in ongoing prelicensure clinical trials that began in the spring of 1987, should ...
J M, Lusher, I, Warrier
openaire +2 more sources
American Pharmacy, 1994
Hemophilias A and B are inherited disorders of clotting-factor production that are characterized by low levels of factor VIII- or IX-coagulant activity. The clinical course of patients with hemophilia is marked by episodes of hemorrhage, some spontaneous and some related to trauma or medical procedures.
openaire +2 more sources
Hemophilias A and B are inherited disorders of clotting-factor production that are characterized by low levels of factor VIII- or IX-coagulant activity. The clinical course of patients with hemophilia is marked by episodes of hemorrhage, some spontaneous and some related to trauma or medical procedures.
openaire +2 more sources
New England Journal of Medicine, 2001
J D, Punch, R M, Merion, J G, Turcotte
openaire +3 more sources
J D, Punch, R M, Merion, J G, Turcotte
openaire +3 more sources
2018
Hemophilia A, B, C, and Acquired Hemophilia A make up a rare group of bleeding disorders that can be challenging to manage in the perioperative setting. The management of hemophilia patients within the surgical setting can require additional planning and extensive health care resources.
openaire +1 more source
Hemophilia A, B, C, and Acquired Hemophilia A make up a rare group of bleeding disorders that can be challenging to manage in the perioperative setting. The management of hemophilia patients within the surgical setting can require additional planning and extensive health care resources.
openaire +1 more source